Related references
Note: Only part of the references are listed.A One-Pot CRISPR/Cas9-Typing PCR for DNA Detection and Genotyping
Jinliang Gao et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2021)
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans
P. J. Maver et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
Jesper Hansen Bonde et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
Ditte Moller Ejegod et al.
BMC CANCER (2020)
Commercially available molecular tests for human papillomaviruses: a global overview
M. Poljak et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study
Louise Kuhn et al.
Lancet Global Health (2020)
Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States
Harvey W. Kaufman et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic
Andrea Ciavattini et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Tackling cervical cancer in Europe amidst the COVID-19 pandemic
Marc Arbyn et al.
Lancet Public Health (2020)
Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework
Ditte Moller Ejegod et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening
Wei Zhang et al.
INFECTIOUS AGENTS AND CANCER (2020)
Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing2
Kayode Olusegun Ajenifuja et al.
INFECTIOUS AGENTS AND CANCER (2020)
Electric field-driven microfluidics for rapid CRISPR-based diagnostics and its application to detection of SARS-CoV-2
Ashwin Ramachandran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation
Li C. Cheung et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)
HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme
N. J. Polman et al.
PREVENTIVE MEDICINE (2019)
HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
Helena Frayle et al.
BMC WOMENS HEALTH (2019)
Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening
Inger Gustavsson et al.
VIROLOGY JOURNAL (2019)
Using the VALGENT-3 framework to assess the clinical and analytical performance of the RIATOL qPCR HPV genotyping assay
I Benoy et al.
JOURNAL OF CLINICAL VIROLOGY (2019)
Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
Marion Saville et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel
D. A. M. Heideman et al.
JOURNAL OF CLINICAL VIROLOGY (2019)
Relative Performance of HPV and Cytology Components of Cotessting in Cervical Screening
Mark Schiffman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Relative Performance of HPV and Cytology Components of Cotessting in Cervical Screening
Mark Schiffman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
Camilla Lagheden et al.
BRITISH JOURNAL OF CANCER (2018)
The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women
X. Zhao et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework
Lan Xu et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Janice S. Chen et al.
SCIENCE (2018)
Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening
Michela Iacobellis et al.
VIROLOGY JOURNAL (2018)
Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
Lan Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework
Anja Ostrbenk et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Validation of EUROArray HPV test using the VALGENT framework
Jessica Viti et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
M. Arbyn et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
Marc Arbyn et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer An Observational Cohort Study
Philip E. Castle et al.
ANNALS OF INTERNAL MEDICINE (2018)
Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions
Marc Arbyn et al.
ANNALS OF INTERNAL MEDICINE (2017)
Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel
N. J. Polman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers
Karl Ulrich Petry et al.
PAPILLOMAVIRUS RESEARCH (2017)
Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea
Sunkyung Jung et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
Ditte Ejegod et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests)
Kate Cuschieri et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework
I. Heard et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
VALGENT: A protocol for clinical validation of human papillomavirus assays
Marc Arbyn et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
A review of the clinical performance of the Aptima HPV assay
Juliane Haedicke et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening
A. T. Hesselink et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Similar Risk Patterns After Cervical Screening in Two Large US Populations Implications for Clinical Guidelines
Julia C. Gage et al.
OBSTETRICS AND GYNECOLOGY (2016)
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Maaike G. Dijkstra et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Maaike G. Dijkstra et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Cervista HPV HR Test for Cervical Cancer Screening A Comparative Study in the Catalonian Population
Francesc Alameda et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
M. Arbyn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
Thomas C. Wright et al.
GYNECOLOGIC ONCOLOGY (2015)
Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework
K. Cuschieri et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening Interim Clinical Guidance
Warner K. Huh et al.
OBSTETRICS AND GYNECOLOGY (2015)
Cervical Cancer Screening by Human Papillomavirus Testing Followed by Cytology Triage
Paolo Giorgi-Rossi et al.
JAMA INTERNAL MEDICINE (2015)
European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
Lawrence von Karsa et al.
PAPILLOMAVIRUS RESEARCH (2015)
Performance of the Xpert HPV assay in women attending for cervical screening
Jack Cuzick et al.
PAPILLOMAVIRUS RESEARCH (2015)
Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control
D. T. Geraets et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Clinical Validation of the HPV-Risk Assay, a Novel Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus DNA by Targeting the E7 Region
A. T. Hesselink et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Clinical Validation of the Cervista HPV HR Test According to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Cancer Screening
Aniek Boers et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection
Min-Jung Kwon et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Are 20 human papillomavirus types causing cervical cancer?
Marc Arbyn et al.
JOURNAL OF PATHOLOGY (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
Marc Arbyn et al.
LANCET ONCOLOGY (2014)
Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
K. Miriam Elfstrom et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study
J. Thomas Cox et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
The Aptima HPV Assay Fulfills the Cross-Sectional Clinical and Reproducibility Criteria of International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
D. A. M. Heideman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Clinical Validation of the Abbott RealTime High Risk HPV Assay According to the Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Screening
A. T. Hesselink et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Correction: HPV Testing by cobas HPV Test in a Population from Catalonia
Belén Lloveras et al.
PLoS One (2013)
Non-inferiority and superiority tests for partially matched data when a constraint is placed on the number of new tests
Peter M. van de Ven et al.
STATISTICS IN MEDICINE (2013)
Clinical Validation of a Type-Specific Real-Time Quantitative Human Papillomavirus PCR against the Performance of Hybrid Capture 2 for the Purpose of Cervical Cancer Screening
C. E. Depuydt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Clinical Human Papillomavirus Detection Forecasts Cervical Cancer Risk in Women Over 18 Years of Follow-Up
Philip E. Castle et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Marc Arbyn et al.
VACCINE (2012)
A Population-Based Clinical Trial Comparing Endocervical High-Risk HPV Testing Using Hybrid Capture 2 and Cervista From the SHENCCAST II Study
Jerome L. Belinson et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA
Gerald Coquillard et al.
GYNECOLOGIC ONCOLOGY (2011)
Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting
F. M. Carozzi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer Screening
Mario Poljak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes
D. A. M. Heideman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition-Summary Document
M. Arbyn et al.
ANNALS OF ONCOLOGY (2010)
A comprehensive evaluation of the accuracy of cervical pre-cancer detection methods in a high-risk area in East Congo
S. Hovland et al.
BRITISH JOURNAL OF CANCER (2010)
Comparison of the Clinical Performance of PapilloCheck Human Papillomavirus Detection with That of the GP5+/6+-PCR-Enzyme Immunoassay in Population-Based Cervical Screening
A. T. Hesselink et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Cervical cytology biobanking in Europe
Marc Arbyn et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2010)
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Chris J. L. M. Meijer et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus
Anna Soederlund-Strand et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
HPV Screening for Cervical Cancer in Rural India
Rengaswamy Sankaranarayanan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Human papillomavirus genotype specificity of Hybrid Capture 2
Philip E. Castle et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China
You-lin Qiao et al.
LANCET ONCOLOGY (2008)
metan: fixed- and random-effects meta-analysis
Ross J. Harris et al.
STATA JOURNAL (2008)
Screen-and-treat approaches for cervical cancer prevention in low-resource settings - A randomized controlled trial
L Denny et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
On tests of equivalence via non-unity relative risk for matched-pair design
NS Tang et al.
STATISTICS IN MEDICINE (2003)
Share Paper
